Your AI-Trained Oncology Knowledge Connection!
Opinion
Video
Panelists discuss available treatment options for patients with chronic graft-vs-host disease (cGVHD) after steroid use, including factors that influence therapy selection, such as mechanism of action (MOA) and the mode of drug administration (oral vs intravenous [IV]).
Video content above is prompted by the following: